Diaceutics (LON:DXRX) Insider Nick Roberts Buys 100 Shares

Diaceutics PLC (LON:DXRX) insider Nick Roberts bought 100 shares of the business’s stock in a transaction on Monday, March 2nd. The shares were bought at an average price of GBX 150 per share, for a total transaction of £150.

Nick Roberts also recently made the following trade(s):

• On Tuesday, December 23rd, Nick Roberts purchased 117 shares of Diaceutics stock. The shares were bought at an average price of GBX 128 per share, with a total value of £149.76.

Diaceutics Stock Performance

Shares of LON DXRX opened at GBX 145.50 on Friday. The business’s 50-day simple moving average is GBX 153.42 and its 200-day simple moving average is GBX 151.80. The company has a debt-to-equity ratio of 3.05, a quick ratio of 9.92 and a current ratio of 3.96. Diaceutics PLC has a 52 week low of GBX 106 and a 52 week high of GBX 176.25. The firm has a market cap of £123.13 million, a price-to-earnings ratio of -80.83 and a beta of 0.58.

Wall Street Analysts Forecast Growth

Separately, Shore Capital Group boosted their price objective on shares of Diaceutics from GBX 180 to GBX 215 and gave the stock a “buy” rating in a research note on Thursday, January 15th. Three equities research analysts have rated the stock with a Buy rating, According to MarketBeat, the company currently has an average rating of “Buy” and an average target price of GBX 193.33.

About Diaceutics

At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world’s leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX – The Diagnostics Network®.